A higher OPG level predicts poor prognosis in subjects with heart failure, diabetes, end-stage kidney disease, coronary artery disease, acute coronary syndrome, and silent myocardial ischemia [16, 17]. This evidence concerns the gene TNFRSF11B and diabetes mellitus.